colesevelam

Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
pharmabiz
Sat, 02/12/11 - 02:26 pm
Biovail
Genzyme
Cholestagel
hypercholesterolemia
colesevelam